Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Pregnancy, Ectopic
Interventions: No intervention; Other
Lead sponsor: Bayer; Industry
Eligibility: 15 Years to 44 Years · Female only
Enrollment: 3,922,877 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hysteroscopy, Hysteroscopy Technique, Fertility Issues, Uterus Abnormal, Gynecology, Visualization, Infertility Female
Interventions: Visual Saline Infusion, Hydrosonography; Device
Lead sponsor: Center for Reproductive Health & Gynecology; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Beverly Hills, California

Conditions: Healthy
Interventions: Guselkumab (lyophilized formulation), Guselkumab (liquid formulation with PFS-U), Guselkumab (liquid formulation with PFS FID), Guselkumab (liquid formulation); Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 3
States / cities: Tempe, Arizona • Lincoln, Nebraska • Neptune City, New Jersey

Conditions: Heart Failure
Interventions: Mesenchymal Precursor cells (RevascorTM), Cryoprotective media alone; Biological · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 17
States / cities: San Diego, California • Washington D.C., District of Columbia • Oak Lawn, Illinois + 12 more

Conditions: Smoking, Smoking Cessation, Smoking Reduction, Smoking Habit, Smoking Behaviors, Smoking, Tobacco, Smoking, Cigarette, Smoking (Tobacco) Addiction, Tobacco Use, Tobacco Smoking
Interventions: Indoor Air Quality Monitor AirGradient ONE; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 8
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Lymphedema of Limb
Interventions: Monterey Pneumatic Compression Device; Device
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Garden Grove, California

Conditions: Overuse Injury
Interventions: Throwing Device; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 8 Years to 14 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hearing Impairment, Deafness
Interventions: RoboHear Device; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Heart Failure
Interventions: Echocardiogram/SonR; Other
Lead sponsor: Piedmont Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pregnancy, Pain
Interventions: Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure, Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure, Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure; Device · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dysfunctional Tear Syndrome
Interventions: InflammaDry; Device
Lead sponsor: Rapid Pathogen Screening; Industry
Eligibility: 18 Years and older
Enrollment: 237 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 4
States / cities: Bradenton, Florida • Springfield, Missouri • Johnson City, New York + 1 more

Conditions: Left Atrial Appendage Closure With WATCHMAN Device Utilizing an Intra-procedural ICE Probe
Interventions: WATCHMAN device implant procedure utilizing ICE probe; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Santa Monica, California • Rochester, Minnesota

Conditions: Obstructive Sleep Apnea
Interventions: Mandibular advancement device (MAD); Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cerebral Palsy (CP)
Interventions: Pediatric Lower Limb Exoskeleton (Bambini Teens); Device
Lead sponsor: COSMO ROBOTICS CO., Ltd; Industry
Eligibility: 5 Years to 14 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Chronic Pain
Interventions: IRIS System; Device
Lead sponsor: PainQx, Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Hidradenitis Suppurativa
Interventions: 1320nm Nd: YAG nonablative laser; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Medical Device, Angiography
Interventions: Boomerang closure device; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Dentin Sensitivity
Interventions: Mouthwash, Potassium nitrate toothpaste, Sodium fluoride toothpaste; Device · Drug
Lead sponsor: Johnson & Johnson Consumer and Personal Products Worldwide; Industry
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Infant Development
Interventions: Prone Positioner; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 44 Weeks to 24 Months
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Sleep-Disordered Breathing
Interventions: Sansa device; Device
Lead sponsor: Huxley Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 533 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 2
States / cities: Decatur, Georgia • Ann Arbor, Michigan

Conditions: Colonic Polyps
Interventions: Capsule swallow; Device
Lead sponsor: Capso Vision, Inc.; Industry
Eligibility: 45 Years to 75 Years
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 11
States / cities: Chula Vista, California • Lancaster, California • Orange, California + 8 more

Conditions: Mastectomy; Lymphedema
Interventions: Ablation; Device
Lead sponsor: SurgiQuest, Inc.; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stress, Breathing Exercise, Stress Management
Interventions: Not listed
Lead sponsor: Livotion, LLC; Industry
Eligibility: 18 Years to 30 Years
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Cerebral Palsy
Interventions: reprogramming assisted communication device interface; Device
Lead sponsor: University of Southern California; Other
Eligibility: 5 Years to 25 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Occurrence and Trend of Pregnancies Growing Outside the Womb (Ectopic Pregnancy) 2009-2018. A Study on a Defined Group of Persons

UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus.

A Study to Assess the Pharmacokinetic Comparability of Guselkumab (CNTO1959) When Delivered by 2 Different Devices and as 2 Formulations in Healthy Participants

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Compact Pneumatic Compression Device for Patients With Lymphedema

Throwing Device Tracker for Youth Injury Prevention

RoboHear™ Device: Advanced Haptic Technology That Allows the Deaf to Understand Speech

Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR Signal

VerTouch Device: A Prospective Randomized Controlled Trial

Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye

The ICE WATCHMAN Trial

Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement

Evaluating the Bambini Teens Exoskeleton for Pediatric Cerebral Palsy

Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa

Evaluating Outcomes in the Placement of Boomerang Percutaneous Device

A Study of the Relief of Tooth Sensitivity of an Experimental Mouthrinse Device

Investigating Fit and Satisfaction of the Prone Positioner

Polysomnography Validation of the Sansa Device

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

ConMed HelixAR™ ElectroSurgical Generator With Argon Beam Coagulation Technology Study

Real World Assessment of Resistance Breathing Device

Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity